Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

2.290

-0.010 (-0.43%)

At close: Jul 24, 2026, 4:00 PM EDT

2.281

-0.009 (-0.41%)

After-hours: Jul 24, 2026, 7:48 PM EDT

Lexicon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	69.64	49.8	31.08	1.2	0.14	0.3
Revenue Growth (YoY)	123.12%	60.24%	2481.48%	766.19%	-53.36%	-98.76%
Cost of Revenue	0.35	0.27	0.62	0.09	-	-
Gross Profit	69.29	49.53	30.47	1.12	0.14	0.3
Selling, General & Admin	34.94	37.32	143.1	113.98	48.08	32.34
Research & Development	58.58	61.12	84.48	58.89	52.82	55.05
Total Operating Expenses	93.52	98.44	227.58	172.87	100.9	87.39
Operating Income	-24.23	-48.91	-197.12	-171.75	-100.76	-87.09
Other Non-Operating Income (Expense)	-4.69	-1.43	-3.29	-5.37	-1.18	-0.67
Total Non-Operating Income (Expense)	-4.69	-1.43	-3.29	-5.37	-1.18	-0.67
Pretax Income	-28.91	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income	-26.09	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income to Common	-26.09	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	373	363	320	221	166	146
Shares Outstanding (Diluted)	373	363	320	221	166	146
Shares Change (YoY)	6.79%	13.44%	44.73%	33.42%	13.79%	31.41%
EPS (Basic)	-0.07	-0.14	-0.63	-0.80	-0.62	-0.60
EPS (Diluted)	-0.07	-0.14	-0.63	-0.80	-0.62	-0.60
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-38.8	-67.85	-179.81	-162.37	-90.18	-88.24
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.10	-0.19	-0.56	-0.73	-0.54	-0.61
Gross Margin	99.49%	99.45%	98.02%	92.94%	100.00%	100.00%
Operating Margin	-34.79%	-98.21%	-634.20%	-14265.00%	-72489.20%	-29224.80%
Profit Margin	-37.46%	-101.08%	-644.78%	-14710.90%	-73341.00%	-29449.00%
FCF Margin	-55.72%	-136.24%	-578.52%	-13485.60%	-64875.50%	-29610.10%
EBITDA	-23.67	-48.29	-196.58	-171.2	-100.33	-86.8
EBITDA Margin	-33.99%	-96.96%	-632.49%	-14218.90%	-72182.00%	-29126.80%
EBIT	-24.23	-48.91	-197.12	-171.75	-100.76	-87.09
EBIT Margin	-34.79%	-98.21%	-634.20%	-14265.00%	-72489.20%	-29224.80%

SEC Filings: 10-K · 10-Q